Global Bioimpedance Devices Market Set to Surge, Projected to Reach US$ 715.1 Million by 2028

Bioimpedance Devices Market
Bioimpedance Devices Market

The global bioimpedance devices market is poised for remarkable growth, with sales projected to exceed US$ 492.1 million in 2022 and expand at a robust CAGR of 6.4% to reach a total market value of US$ 715.1 million by 2028.

This significant uptick in market value can be attributed to several key factors driving demand. The proliferation of sports rehabilitation centers, weight loss clinics, and fitness clubs worldwide is fueling the adoption of bioelectrical impedance devices. Furthermore, growing awareness about the benefits of maintaining a healthy lifestyle among the general populace is amplifying the demand for these innovative devices.

Request For A Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-5563

Bioimpedance machines offer invaluable benefits, including the ability to predict muscle mass and enhance the rate of glomerular activity in patients. As technological advancements in glomerular filtration rate detection continue to progress, the market is witnessing the development of compact, lightweight, and user-friendly devices, further bolstering their demand.

“The rising emphasis on preventive healthcare and the growing preference for non-invasive diagnostic techniques are key factors propelling the Bioimpedance Devices Market forward,” stated a FMI. “We anticipate continued growth in the market as manufacturers focus on innovation and product development to meet evolving consumer needs.”

With the projected surge in demand, market players are gearing up to capitalize on emerging opportunities, driving investments in research and development to introduce advanced bioimpedance devices to the market.

Key Takeaways Bioimpedance Devices Market:

  • Definition of Bioimpedance Devices: Bioimpedance devices are medical instruments that measure the impedance (resistance and reactance) of biological tissues to assess various physiological parameters. These devices use electrical currents at different frequencies to gather information about body composition, fluid levels, and other health-related metrics.
  • Applications:
    • Body Composition Analysis: Bioimpedance devices can estimate body fat percentage, lean body mass, and hydration levels, which are crucial for assessing overall health and fitness.
    • Edema Monitoring: These devices are used to monitor changes in extracellular fluid levels, aiding in the management of conditions like congestive heart failure and kidney diseases.
    • Nutritional Assessment: Bioimpedance measurements can provide insights into nutritional status, helping clinicians design appropriate dietary plans.
    • Athletic Performance: Athletes use bioimpedance devices to track changes in muscle mass and fluid balance, optimizing training and recovery strategies.
  • Types of Bioimpedance Devices:
    • Single-Frequency Devices: These devices operate at a fixed frequency and are simpler, often used for basic body composition measurements.
    • Multi-Frequency Devices: These devices use multiple frequencies to provide more accurate and detailed measurements of various body compartments.
    • Segmental Devices: Some bioimpedance devices can measure impedance in specific body segments, offering insights into regional variations in body composition.
  • Market Growth Drivers:
    • Rising Health Awareness: Growing awareness about the importance of maintaining a healthy lifestyle has driven the demand for tools that provide accurate health assessments.
    • Aging Population: The aging global population has increased the need for medical devices that can monitor conditions related to age, such as fluid retention and muscle loss.
    • Sports and Fitness Industry: The fitness and sports sectors use bioimpedance devices to track progress and tailor training regimens.

Get Customization on This Report: https://www.futuremarketinsights.com/customization-available/rep-gb-5563

Competition Landscape:

Major players in the global market are heavily investing in research and development endeavors to pioneer cutting-edge bioimpedance machines. Concurrently, they are actively engaging health-conscious consumers through awareness campaigns. Meanwhile, other contenders are strategizing to broaden their market reach and enhance distribution networks to maintain their leadership positions.

For instance:

  • In January 2022, Withings, a renowned French consumer electronics company, unveiled the Withings Body Scan scale, a groundbreaking smart scale, at the Consumer Electronics Show. This innovative scale incorporates ECG capabilities through a set of electrodes and four weight sensors. It not only estimates vascular age and measures heart rate but also offers multi-frequency bioelectrical impedance analysis to accurately gauge percentages of bone, water, muscle, and fat.
  • In August 2021, Samsung, a leading South Korean multinational electronics corporation, launched its latest offerings, the ‘Galaxy Watch4 Classic’ and ‘Galaxy Watch4,’ in India. Marking a significant leap in the smartwatch industry, this new series introduces body composition capabilities for the first time, empowering users to take charge of their health seamlessly. Designed for all-day wear, Samsung aims to promote holistic health and wellness with these innovative smartwatches.

Top Companies Profiled:

  • General Electric Company
  • Omron Corporation
  • Fresenius Medical Care
  • ImpediMed Limited
  • SELVAS AI Inc.
  • Tanita Corporation
  • RJL Systems, Inc.
  • Maltron International Ltd.
  • Bodystat Limited
  • SMT Medical GmbH

Bioimpedance Devices Market Segmentation:

Product Type:

  • Single-frequency Bioimpedance Devices
  • Multiple-frequency Bioimpedance Devices

Modality:

  • Wired Bioimpedance Devices
  • Wireless Bioimpedance Devices

End Users:

  • Hospitals
  • Specialty Clinics
  • Rehabilitation Centers
  • Others

Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Japan
  • Asia Pacific excluding Japan
  • Middle East & Africa (MEA)

Get Exclusive Purchase Now to Access: https://www.futuremarketinsights.com/checkout/5563

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

About the Author

Ronak Shah

Associate Vice President at Future Market Insights is deeply committed to uncovering actionable insights for consumer and food and beverage players. She brings a unique blend of analysis, industry trends, and consumer behavior to put data into perspective.

What she makes out of data becomes a delight to read. She has authored many opinions, including for publications like Process Industry Informer and Spinal Surgery News, as she understands the market pulse and consumers' shifting preferences.

She likes to bring experts to a roundtable to weigh the impact of a trend on an industry. Catch up with her discussion on the impact of AI in packaging.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these